- Biocon Limited has launched its GLP-1 peptide, Liraglutide, in the United Kingdom for diabetes and obesity.
- The drug will be marketed under the brand names Liraglutide Biocon (gVictoz…
Join the vibrant privacy-ensured Dzambhala community on
Want to give feedback on this story? Write to us at [email protected]